This is due to the consequent repression of the proto-oncogene BCL6 expression [206] whose dysregulation in part directly or indirectly represses PRDM1 and is implicated in the pathogenesis of B-cell lymphoma, mainly of DLBCL [207]. Here, PRDM1 is linked to B-cell non-Hodgkin lymphoma.